5/8
04:46 pm
scyx
SCYNEXIS Reports First Quarter 2024 Financial Results and Provides Corporate Update [Yahoo! Finance]
Low
Report
SCYNEXIS Reports First Quarter 2024 Financial Results and Provides Corporate Update [Yahoo! Finance]
5/8
04:30 pm
scyx
SCYNEXIS Reports First Quarter 2024 Financial Results and Provides Corporate Update
Low
Report
SCYNEXIS Reports First Quarter 2024 Financial Results and Provides Corporate Update
5/8
12:18 pm
scyx
Investors in SCYNEXIS (NASDAQ:SCYX) have unfortunately lost 87% over the last five years [Yahoo! Finance]
Low
Report
Investors in SCYNEXIS (NASDAQ:SCYX) have unfortunately lost 87% over the last five years [Yahoo! Finance]
4/30
04:14 pm
scyx
SCYNEXIS Presented Preclinical Data on Second Generation Fungerp SCY-247 at the Congress of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID Global, Formerly ECCMID) [Yahoo! Finance]
Low
Report
SCYNEXIS Presented Preclinical Data on Second Generation Fungerp SCY-247 at the Congress of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID Global, Formerly ECCMID) [Yahoo! Finance]
4/30
04:05 pm
scyx
SCYNEXIS Presented Preclinical Data on Second Generation Fungerp SCY-247 at the Congress of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID Global, Formerly ECCMID)
Low
Report
SCYNEXIS Presented Preclinical Data on Second Generation Fungerp SCY-247 at the Congress of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID Global, Formerly ECCMID)
4/9
04:15 pm
scyx
SCYNEXIS to Present Preclinical Data on Second Generation Fungerp SCY-247 at the 34th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) [Yahoo! Finance]
Medium
Report
SCYNEXIS to Present Preclinical Data on Second Generation Fungerp SCY-247 at the 34th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) [Yahoo! Finance]
4/9
04:05 pm
scyx
SCYNEXIS to Present Preclinical Data on Second Generation Fungerp SCY-247 at the 34th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)
Medium
Report
SCYNEXIS to Present Preclinical Data on Second Generation Fungerp SCY-247 at the 34th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)
4/2
10:06 am
scyx
Scynexis: Update Following Restructuring Of GSK Deal [Seeking Alpha]
Medium
Report
Scynexis: Update Following Restructuring Of GSK Deal [Seeking Alpha]
4/1
09:01 am
scyx
SCYNEXIS, Inc. (NASDAQ: SCYX) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
Medium
Report
SCYNEXIS, Inc. (NASDAQ: SCYX) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
3/28
04:19 pm
scyx
SCYNEXIS Reports Full Year 2023 Financial Results and Provides Corporate Update [Yahoo! Finance]
Low
Report
SCYNEXIS Reports Full Year 2023 Financial Results and Provides Corporate Update [Yahoo! Finance]
3/28
04:01 pm
scyx
SCYNEXIS Reports Full Year 2023 Financial Results and Provides Corporate Update
Low
Report
SCYNEXIS Reports Full Year 2023 Financial Results and Provides Corporate Update
3/18
11:06 pm
scyx
SCYNEXIS, Inc. (NASDAQ: SCYX) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
Medium
Report
SCYNEXIS, Inc. (NASDAQ: SCYX) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
2/22
11:05 pm
scyx
SCYNEXIS, Inc. (NASDAQ: SCYX) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Low
Report
SCYNEXIS, Inc. (NASDAQ: SCYX) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.